AAV vectors containing the combined furin-site and 2A 'self-cleaving' peptide facilitate high-level expression of monoclonal antibodies in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fang, J. et al. Nat. Biotechnol. 23, 584–590 (2005).
Lobo, E.D., Hansen R.J. & Balthasar J.P. J. Pharm. Sci. 93, 2645–2668 (2004).
Flotte, T.R. Gene Ther. 11, 805–810 (2004).
de Felipe, P. Genet. Vaccines & Ther. 2, 13 (2004).
de Felipe, P. & Ryan, M.D. Traffic 5, 616–626 (2004).
Gaken, J. et al. Gene Ther. 7, 1979–1985 (2000).
Gao, G.-P. et al. Proc. Natl. Acad. Sci. USA 99, 11854–11859 (2002).
Nakai, H. et al. J. Virol. 79, 214–224 (2005).
Jooss, K. & Chirmule, N. Gene Ther. 10, 955–963 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marasco, W. Therapeutic antibody gene transfer. Nat Biotechnol 23, 551–552 (2005). https://doi.org/10.1038/nbt0505-551
Issue Date:
DOI: https://doi.org/10.1038/nbt0505-551
This article is cited by
-
Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer
Cancer Gene Therapy (2010)
-
Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV
Cancer Gene Therapy (2009)
-
An Antibody Delivery System for Regulated Expression of Therapeutic Levels of Monoclonal Antibodies In Vivo
Molecular Therapy (2007)
-
Gene Therapy Progress and Prospects – Vectorology: design and production of expression cassettes in AAV vectors
Gene Therapy (2006)